|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 |
| (11) | Number of the document | 3169797 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15734713.9 |
| Date of filing the European patent application | 2015-07-13 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/065986 |
| Date | 2015-07-13 |
| (87) | Number | WO 2016/008853 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 14176944 | 2014-07-14 | EP |
| (72) |
LEVESQUE, Mitchell Paul, CH
DUMMER, Reinhard, CH
WIDMER, Daniel, CH
RAAIJMAKERS, Marieke Ineke Geertje, CH
|
| (73) |
Universität Zürich Prorektorat MNW,
Rämistrasse 71, 8006 Zürich,
CH
|
| (54) | MEANS AND METHODS FOR IDENTIFYING A PATIENT HAVING A BRAF-POSITIVE CANCER AS A NON-RESPONDER TO A BRAF INHIBITOR AND AS A RESPONDER TO AN MAPK/ERK INHIBITOR |
| MEANS AND METHODS FOR IDENTIFYING A PATIENT HAVING A BRAF-POSITIVE CANCER AS A NON-RESPONDER TO A BRAF INHIBITOR AND AS A RESPONDER TO AN MAPK/ERK INHIBITOR |